Latest Insider Transactions at Epizyme, Inc. (EPZM)
This section provides a real-time view of insider transactions for Epizyme, Inc. (EPZM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Epizyme, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Epizyme, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2021
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+5.05%
|
$19,000
$2.5 P/Share
|
|
Dec 06
2021
|
Shefali Agarwal |
SELL
Open market or private sale
|
Direct |
1,780
-1.08%
|
$3,560
$2.93 P/Share
|
|
Nov 16
2021
|
Carol Stuckley Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,702
+50.0%
|
-
|
|
Nov 16
2021
|
Beveridge, Roy A Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,702
+50.0%
|
-
|
|
Sep 30
2021
|
Kevin T Conroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,930
+10.85%
|
$14,650
$5.12 P/Share
|
|
Sep 30
2021
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,640
+2.67%
|
$23,200
$5.12 P/Share
|
|
Aug 16
2021
|
Shefali Agarwal |
BUY
Grant, award, or other acquisition
|
Direct |
59,166
+26.57%
|
-
|
|
Aug 16
2021
|
Grant C. Bogle President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
87,500
+47.8%
|
-
|
|
Aug 16
2021
|
Matthew Ros Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,125
+20.17%
|
-
|
|
Aug 16
2021
|
Joseph Beaulieu Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,833
+34.42%
|
-
|
|
Aug 16
2021
|
Jeffery Kutok Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,832
+31.46%
|
-
|
|
Jun 30
2021
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,858
+1.71%
|
$22,864
$8.31 P/Share
|
|
Jun 30
2021
|
Kevin T Conroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,805
+7.86%
|
$14,440
$8.31 P/Share
|
|
Jun 11
2021
|
Victoria Richon Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,060
+37.19%
|
-
|
|
Jun 11
2021
|
Carl Goldfischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,060
+38.16%
|
-
|
|
Jun 11
2021
|
Kevin T Conroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,060
+29.41%
|
-
|
|
Jun 11
2021
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,060
+4.75%
|
-
|
|
Jun 11
2021
|
Andrew R Allen Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,060
+28.16%
|
-
|
|
Jun 11
2021
|
Michael F Giordano Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,060
+50.0%
|
-
|
|
Jun 11
2021
|
Grant C. Bogle President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,060
+50.0%
|
-
|
|
Jun 11
2021
|
Kenneth Bate Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,060
+50.0%
|
-
|
|
Apr 05
2021
|
Jeffery Kutok Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,029
-3.62%
|
$16,232
$8.8 P/Share
|
|
Mar 31
2021
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,727
+1.74%
|
$21,816
$8.71 P/Share
|
|
Mar 31
2021
|
Kevin T Conroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,723
+13.25%
|
$13,784
$8.71 P/Share
|
|
Mar 26
2021
|
David M Mott Director |
BUY
Open market or private purchase
|
Direct |
34,486
+9.34%
|
$241,402
$7.89 P/Share
|
|
Mar 25
2021
|
Robert B Bazemore President & CEO |
SELL
Open market or private sale
|
Direct |
10,328
-3.1%
|
$72,296
$7.85 P/Share
|
|
Mar 25
2021
|
David M Mott Director |
BUY
Open market or private purchase
|
Direct |
28,231
+19.52%
|
$197,617
$7.98 P/Share
|
|
Feb 04
2021
|
Victoria Vakiener Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
817
-1.53%
|
$8,987
$11.21 P/Share
|
|
Feb 04
2021
|
Matthew Ros Officer |
SELL
Open market or private sale
|
Direct |
894
-1.06%
|
$9,834
$11.21 P/Share
|
|
Feb 04
2021
|
Joseph Beaulieu Officer |
SELL
Open market or private sale
|
Direct |
227
-1.66%
|
$2,497
$11.21 P/Share
|
|
Feb 04
2021
|
Paolo Tombesi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,021
-1.87%
|
$11,231
$11.21 P/Share
|
|
Feb 04
2021
|
Shefali Agarwal |
SELL
Open market or private sale
|
Direct |
969
-0.92%
|
$10,659
$11.21 P/Share
|
|
Feb 04
2021
|
Robert B Bazemore President & CEO |
SELL
Open market or private sale
|
Direct |
3,890
-1.16%
|
$42,790
$11.21 P/Share
|
|
Feb 01
2021
|
Jeffery Kutok Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,645
+33.82%
|
-
|
|
Feb 01
2021
|
Matthew Ros Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,125
+25.07%
|
-
|
|
Feb 01
2021
|
Victoria Vakiener Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,520
+32.29%
|
-
|
|
Feb 01
2021
|
Paolo Tombesi Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,041
+32.34%
|
-
|
|
Feb 01
2021
|
Joseph Beaulieu Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,700
+36.05%
|
-
|
|
Feb 01
2021
|
Robert B Bazemore President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
87,500
+20.67%
|
-
|
|
Feb 01
2021
|
Shefali Agarwal |
BUY
Grant, award, or other acquisition
|
Direct |
29,583
+21.93%
|
-
|
|
Jan 25
2021
|
Shefali Agarwal |
SELL
Open market or private sale
|
Direct |
2,872
-3.65%
|
$31,592
$11.41 P/Share
|
|
Jan 25
2021
|
Victoria Vakiener Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
599
-2.1%
|
$6,589
$11.41 P/Share
|
|
Jan 25
2021
|
Matthew Ros Officer |
SELL
Open market or private sale
|
Direct |
2,872
-4.88%
|
$31,592
$11.41 P/Share
|
|
Jan 25
2021
|
Robert B Bazemore President & CEO |
SELL
Open market or private sale
|
Direct |
6,069
-2.39%
|
$66,759
$11.41 P/Share
|
|
Dec 31
2020
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,158
+2.39%
|
$21,580
$10.86 P/Share
|
|
Dec 31
2020
|
Kevin T Conroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+9.68%
|
$10,240
$10.86 P/Share
|
|
Dec 03
2020
|
Shefali Agarwal |
SELL
Open market or private sale
|
Direct |
2,522
-3.21%
|
$32,786
$13.54 P/Share
|
|
Nov 11
2020
|
Carl Goldfischer Director |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$60,000
$12.07 P/Share
|
|
Sep 30
2020
|
Kevin T Conroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
933
+9.85%
|
$10,263
$11.93 P/Share
|
|
Sep 30
2020
|
David M Mott Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,965
+2.23%
|
$21,615
$11.93 P/Share
|